Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is GBX 198.60.
A number of research firms have recently issued reports on ONT. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a research note on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 195 target price on shares of Oxford Nanopore Technologies in a report on Thursday, August 20th. Berenberg Bank dropped their target price on Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating on the stock in a research report on Wednesday, August 19th. Citigroup downgraded Oxford Nanopore Technologies to a “buy” rating in a research note on Monday, July 20th. Finally, Peel Hunt restated a “hold” rating and set a GBX 153 target price on shares of Oxford Nanopore Technologies in a research report on Monday, July 13th.
Oxford Nanopore Technologies Stock Performance
Oxford Nanopore Technologies (LON:ONT – Get Free Report) last released its quarterly earnings data on Wednesday, August 19th. The company reported GBX (4.90) earnings per share for the quarter. Oxford Nanopore Technologies had a negative net margin of 54.66% and a negative return on equity of 35.45%.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Featured Stories
- Five stocks we like better than Oxford Nanopore Technologies
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
